Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Italy Revenue	182.68M	176.52M	173.54M
Italy Revenue Growth	3.48%	1.72%	-12.14%
Europe Revenue	293.02M	288.15M	265.21M
Europe Revenue Growth	1.69%	8.65%	-1.53%
North America Revenue	641.35M	618.94M	607.36M
North America Revenue Growth	3.62%	1.91%	-22.41%
Rest of the World Revenue	98.45M	101.81M	102.10M
Rest of the World Revenue Growth	-3.30%	-0.28%	-8.48%

EBIT by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Italy Operating Profit	99.85M	104.56M	73.67M
Italy Operating Profit Growth	-4.50%	41.93%	-37.98%
Europe Operating Profit	26.87M	24.35M	19.05M
Europe Operating Profit Growth	10.33%	27.84%	-32.14%
North America Operating Profit	151.32M	140.76M	106.16M
North America Operating Profit Growth	7.50%	32.59%	-49.67%
Rest of the World Operating Profit	504.00K	1.27M	1.69M
Rest of the World Operating Profit Growth	-60.16%	-24.97%	-39.59%
Eliminations from Operating Profit	-13.74M	-12.61M	15.70M

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Ex-COVID Immunodiagnostics % of Revenue	66.20%	62.70%
Ex-COVID Molecular Diagnostics % of Revenue	17.20%	17.20%
Licensed Technologies % of Revenue	14.40%	15.00%
COVID % of Revenue	2.20%	5.10%

Updated Jun 30, 2025. Data Source: Fiscal.ai.